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of NK cells via NKG2C is also enhanced 
via co-stimulation. Co-engagement of 
the co-stimulatory molecule CD2 and 
exposure to the pro-inflammatory cytokines 
IL-12 and IL-18 enhance the responses of 
NKG2C+ NK cells. Together, differences 
in the UL40 peptide sequence and in 
the concentrations of pro-inflammatory 
cytokines might explain the large differences 
in the frequency of adaptive NKG2C+  
NK cells noted in HCMV-infected people.
The recognition of certain UL40 peptides 
by NKG2C can stimulate existing NKG2C+ 
NK cells from HVMC+ people. But can it 
also drive the expansion and differentiation 
of a population of NKG2C+ NK cells from 
uninfected people and thereby recapitulate 
the events during an HCMV infection? 
The data of Hammer et al. show that a 
combination of the engagement of NKG2C 
by UL40-derived peptides and the pro-
inflammatory cytokines IL-12 and IL-18 
is able to selectively drive the expansion 
and differentiation of an NKG2C+ NK 
cell population from HCMV-seronegative 
people2. This expanded NK cell population 
shows changes in its transcriptional profile 
and in the methylation pattern of the IFNG 
promoter reminiscent of what has been 
described for adaptive NK cells. Finally, these 
findings are confirmed in a small cohort of 
patients who have undergone hematopoietic 
stem cell transplantation and show HCMV 
reactivation. The data of Hammer et al. 
suggest that sequence variations in HCMV 
can differentially affect the recognition 
of infected cells via NKG2C and thereby 
contribute to the size and the heterogeneity 
of the adaptive NKG2C+ NK cell subset2.
There has been a long co-evolution 
between HCMV and the human immune 
system3. Why would HCMV keep UL40 
peptides that selectively engage NKG2C 
presented by HLA-E and thereby drive the 
activation of NK cells? Actually, the peptide 
with the greatest NKG2C-stimulating 
ability is found in only about 1% of clinical 
HCMV isolates, suggestive of selective 
pressure against such peptides. However, 
the second-best stimulating UL40 peptide is 
found in 40% of HCMV isolates. The main 
function of the UL40 peptide is probably 
stabilization of HLA-E, which provides 
sufficient inhibition of NK cell responses 
via NKG2A. Therefore, it might not be 
easy to maintain HLA-E stabilization and 
NKG2A engagement while limiting the 
stimulation of NKG2C+ NK cells. This 
struggle is reflected by the fact that there is 
high sequence variability only within the 
nonameric peptide of UL40 that binds to 
HLA-E, not in the surrounding region.
Expansion of the adaptive NKG2C+ NK 
cell population has also been reported for 
infection with other viruses, but only in 
HCMV-seropositive people10. How can this 
be explained? UL40 peptides and probably 
other HCMV-related factors seem to be 
important for the initial stimulation and 
expansion of an adaptive NKG2C+ NK cell 
population. However, peptides from other 
viruses or even endogenous peptides might 
mimic the function of UL40 and, after 
presentation via HLA-E, sufficiently stimulate 
existing adaptive NKG2C+ NK cells together 
with pro-inflammatory cytokines during the 
infection. Interestingly, HCMV can drive the 
expansion of an adaptive NK cell population 
even in people who lack KLRC2, the gene 
that encodes NKG2C11. These adaptive 
NK cells ‘preferentially’ express activating 
killer cell immunoglobulin-like receptors 
(KIRs). One might speculate that other viral 
ligands or HCMV-derived peptides that are 
presented by classical MHC class I molecules 
might ‘preferentially’ engage activating KIRs 
rather than their inhibitory counterpart, 
which could represent another peptide-
specific recognition strategy of NK cells.
Activating KIRs and NKG2C signal 
via adaptor molecules that contain 
immunoreceptor tyrosine-based activation 
motifs (ITAMs). There are other NK cell 
receptors that use ITAM signaling, such 
as NKp46, NKp44, NKp30 and CD16. 
Among these receptors, NKp46 and NKp44 
can recognize diverse viral ligands12. The 
engagement of NKp46 and NKp44 by these 
viral ligands could also drive the expansion 
of an adaptive NK cell population. 
Therefore, it might be a general mechanism 
that engagement of ITAM-coupled receptors 
in combination with pro-inflammatory 
cytokines can provide the necessary  
signals for the expansion of an adaptive  
NK cell population.
The identification of the murine 
cytomegalovirus protein m157 as a specific 
antigen for Ly49H was essential for the 
substantial advancement of knowledge 
about adaptive NK cell responses in mice. 
The finding that UL40 peptides are specific 
antigens for expansion of the adaptive 
NKG2C+ NK cell population in humans 
should similarly boost novel and exciting 
research into human adaptive NK cells. ❐
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γ δ 17 T CELLS
Got my γδ17 T cells to keep me warm
γ δ T cells accumulate with age in adipose tissue and produce the cytokine IL-17, which controls the homeostasis of 
regulatory T cells and adaptive thermogenesis. Thus, maintenance of core body temperature unexpectedly relies on 
these adipose tissue–resident γ δ 17 T cells.
Pedro H. Papotto    and Bruno Silva-Santos
While they share many functional properties with their α β T cell counterparts, γ δ T cells typically mount very rapid responses that align with innate (rather than adaptive) immunity. These kinetics are particularly clear for antigen-nonspecific production of the cytokine IL-17 by γ δ T cells in response to inflammatory cytokines (IL-23 and IL-1β ),  
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Fig. 1 | Adipose tissue–resident γδ t cells secrete Il-17 and tNF, which control thermogenesis.  
The cellular and molecular mechanisms that operate in adipose tissue at thermoneutrality (left) or  
after exposure to cold (right). Adipose tissue–resident γ δ 17 T cells express Vγ6+ T cell antigen receptors 
and the transcription factors RORγ t and PLZF. During aging, adipose tissue γ δ 17 T cells increase in 
number and, through the production of IL-17A and TNF, stimulate IL-17R+ stromal cells to secrete  
IL-33, which underlies the accumulation of ST2+ Treg cells and the maintenance of tissue homeostasis.  
In contrast, after exposure to cold, IL-17A and TNF act directly on adipocytes to induce a UCP1-dependent 
thermogenic program. IL-17R, IL-17 receptor; PDGFRα , growth-factor receptor; Pdpn, podoplanin; Ucl1, 
Dio2, Cidea, Il33, genes upregulated after exposure to cold.Credit: Katie Vicari/Springer Nature
which precedes the contribution of the TH17 
subset of helper T cells to multiple disease 
models1. A distinctive characteristic of 
IL-17-producing γ δ T cells (γ δ 17 T cells) 
that underlies this phenomenon is their 
‘developmental pre-programming’ in the 
fetal thymus1–3. Interestingly, as they egress 
from the thymus, γ δ 17 T cells populate a 
discrete set of non-lymphoid tissues, such  
as the peritoneal cavity, lungs, dermis, 
tongue and uterus, where they are sustained 
as self-renewing, long-lived cells. In this 
issue of Nature Immunology, Kohlgruber  
et al. characterize a population of γ δ 17  
T cells that accumulate in the adipose tissue, 
which unexpectedly controls adaptive 
thermogenesis and thus the maintenance of 
core body temperature4.
The adipose tissue harbors myriad 
immune cell populations with different 
functions. Among these, regulatory T cells 
(Treg cells) have been critically linked to 
obesity and insulin resistance5,6. Adipose 
tissue Treg cells have been shown to be 
maintained in young adult mice by a 
resident population of natural killer T cells7. 
However, whereas the number of natural 
killer T cells in adipose tissue decreases with 
age4, the number of Treg cells continuously 
increases5–7, which suggests that another 
cellular mechanism might underlie Treg cell 
homeostasis in aged mice. Kohlgruber et al.  
now find that the number of γ δ T cells 
increases concurrently with that of Treg cells 
in aging mice, with the adipose tissue of 
mice older than 20 weeks of age showing 
considerable enrichment for these cells4.  
Of note, γ δ T cells also make up a substantial 
fraction of lymphocytes in human adipose 
tissue4. Further characterization of adipose 
tissue–resident γ δ T cells in mice has  
shown that they express the transcription 
factor PLZF, the key developmental 
regulator of innate-like lymphocytes, and 
bear Vγ6+ T cell antigen receptors (TCRs), 
characteristic of fetal thymus–derived γ δ  
T cells1. Notably, mice that lack all γ δ T cells, 
or, more specifically, Vγ6+PLZF+ γ δ T cells,  
are impaired in their age-dependent 
accumulation of Treg cells4. Adipose tissue 
γ δ T cells also express the type 17 master 
transcription factor RORγ t while lacking 
expression of CD27, a member of the  
tumor-necrosis factor (TNF) receptor 
superfamily, both characteristics of γ δ 17  
T cells2. Consistent with that, when 
stimulated in vitro with IL-1β and IL-23, 
they produce abundant IL-17A, as well as 
TNF. Notably, these cytokines stimulate 
stromal cells expressing the IL-17 receptor 
to produce IL-33 in vivo and thus provide 
a molecular link to Treg cells expressing the 
IL-33 receptor ST2 in the adipose tissue4.  
Of note, IL-17A deficiency results in 
profound depletion of adipose tissue Treg cells. 
Moreover, primary culture of human 
preadipocytes in the presence of IL-17A  
and TNF also induces substantial 
production of IL-33.
Since IL-33 is a potent stimulus of 
thermogenesis8, Kohlgruber et al. investigate 
the effect of IL-17A and TNF on this 
process and find that the two cytokines 
synergistically induce a thermogenic 
program that is dependent on the 
uncoupling protein UCP1 and is required 
for lipolysis induction4. Unexpectedly, 
IL-17A and TNF act directly on stromal cells 
and differentiated adipocytes independently 
of IL-33. Consequently, mice that lack either 
γ δ T cells or IL-17A show substantial defects 
in the maintenance of body temperature 
(i.e., they display lower body temperatures 
and higher breathing activity than that 
of their wild-type counterparts) both at 
thermoneutrality and especially after cold 
challenge (Fig. 1).
Until now, γ δ 17 T cells have been 
associated mostly with inflammatory 
responses, both in protective immunity 
to fungal and bacterial infections and in 
pathogenic autoinflammation1. On the  
other hand, γ δ 17 T cells, together with  
type 3 innate lymphoid cells, constitute 
major sources of IL-17A in various 
peripheral tissues at steady state and might 
thus contribute decisively to their normal 
physiology. In fact, IL-17A, provided 
mainly by γ δ 17 T cells, has been shown to 
inhibit adipogenesis and regulate glucose 
metabolism and thus control diet-induced 
obesity9. Together with the current study4, 
these results establish the importance of  
γ δ 17 T cells in adipose tissue. Elsewhere, 
γ δ 17 T cells have been linked to bone 
regeneration through IL-17A-mediated 
stimulation of the proliferation and 
osteoblastic differentiation of mesenchymal 
progenitor cells10. However, the physiological 
roles of γ δ 17 T cells in other tissues in which 
they reside, such as the uterus or the lungs, 
remain to be clarified.
We postulate that γ δ 17 T cells might 
shape tissue architecture starting at  
early life and actively participate in key 
physiological processes throughout  
life. When investigating this possibility, 
it will be important to consider some 
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unresolved fundamental issues in γ δ 17  
T cell biology, such as the extent to which  
γ δ 17 T cell responses rely on thymically  
pre-programmed effector cells (‘thymic  
γ δ 17 T cells’) or inflammation-induced 
‘peripheral γ δ 17 T cells’. Thus, in addition 
to long-standing thymic γ δ 17 T cells1–3, 
peripheral γ δ 17 T cells can be generated 
from uncommitted precursor cells in 
secondary lymphoid organs exposed to 
inflammatory IL-23 and IL-1β signals11,12. 
That finding has been observed in mouse 
models of the critical autoinflammatory 
diseases multiple sclerosis11 and psoriasis12. 
Interestingly, both reports demonstrated the 
potential of Vγ4+ γ δ T cells to differentiate 
into IL-17A-producing cells in the periphery, 
whereas Vγ6+ γ δ 17 T cells are expected to 
develop exclusively in the fetal thymus1. 
Taking into account that the current study 
by Kohlgruber et al. demonstrates that 
adipose tissue γ δ 17 T cells are mostly  
Vγ6+ cells4, we are tempted to speculate  
a dichotomy between tissue-resident 
‘thymic’ Vγ6+ γ δ 17 T cells that support 
physiological functions and tissue 
regeneration and recruited ‘peripheral’ 
Vγ4+ γ δ 17 T cells that participate in 
autoinflammatory processes, although some 
exceptions to this working model have 
been reported1. Notably, when it comes to 
immunity to infectious microorganisms, 
protective γ δ 17 T cell responses seemingly 
rely on both tissue-resident Vγ6+ cells and 
lymphoid Vγ4+ cells1.
In the case of tissue-resident Vγ6+ γ 
δ 17 T cells, it will be relevant to clarify 
which signals are responsible for their local 
activation. As inflammatory cytokines 
(IL-23 and IL-1β ) probably do not have 
a substantial role at steady state, other 
molecular cues must account for the ‘basal’ 
production of IL-17A. TCR signals remain 
logical but highly controversial candidates1. 
In any case, it is interesting to question the 
evolutionary meaning of having Vγ6+ γ δ 
17 T cells, the product of intricate T cell 
antigen receptor rearrangement coupled 
with thymic effector ‘pre-programming’, as 
key providers of IL-17A in situ, when other 
innate lymphoid population (type 3 innate 
lymphoid cells) can also reside in peripheral 
non-lymphoid tissues and secrete IL-17A.  
In conclusion, the findings of Kohlgruber  
et al.4 heat up long-standing discussions 
while opening new paths for better 
understanding of the primordial roles of γ δ 
T cells in their vertebrate hosts. ❐
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GENE REGULATION
c-Maf in CD4+ T cells: it’s all about context
The role of the transcription factor c-Maf varies in different CD4+ T cell subsets and can be associated with either 
pro-inflammatory activity or anti-inflammatory activity, depending on the cell context.
W. Nicholas Haining and Sarah A. Weiss
One of the most fundamental questions in biology is how a cell ‘decides’ to take on one fate 
over another and how that fate is stably 
maintained over the lifetime of the cell. In 
immunology, CD4+ T cells have provided 
an instructive model for understanding 
the regulation of cell-fate ‘decisions’1–4. 
Depending on environmental cues, such 
as signaling via the T cell antigen receptor 
and the cytokine milieu5,6, CD4+ T cells 
develop into one of several subsets that are 
specialized to provide protection against 
specific types of pathogens. The TH1 subset 
of helper T cells, crucial for defense against 
intracellular pathogens, is characterized by 
production of the cytokine IFN-γ .  
TH2 cells, defined by IL-4 production, 
are involved in both protection against 
helminths and allergic responses. A third 
subset, TH17 cells, expressed the cytokine 
IL-17 and defends against extracellular 
bacteria and fungi. TH17 cells have also been 
linked to the pathogenesis of autoimmune 
diseases, including colitis and encephalitis. 
Finally, CD4+ T cells can differentiate 
into regulatory T cells (Treg cells), which 
act to dampen inflammatory responses 
and are characterized by expression of the 
transcription factor Foxp3. In the current 
issue of Nature Immunology, Gabryšová 
et al. show that the effect of deleting the 
transcription factor c-Maf in different CD4+ 
T cell subsets has a very different outcome 
depending on the cell context7 (Fig. 1).
Previously what made those subsets 
appealing to study was that for each, 
a key transcription factor required for 
development had been identified8: T-bet 
for TH1 cells, Gata3 for TH2 cells, RoRyt 
for TH17 cells and Foxp3 for Treg cells9,10. 
However, state-specific patterns of gene 
expression are not regulated solely by a 
specific set of transcription factors. Instead, 
each cell type is associated with a distinct 
epigenetic state: the pattern of localization 
and modification of histones and their 
underlying DNA9. These factors dictate 
which regions of the genome are accessible 
to the transcription factors that govern the 
transcriptional activity of adjacent genes. 
Methods such as the assay for transposase-
accessible chromatin followed by deep 
sequencing (ATAC-Seq)11 have been used 
to identify regions of open, accessible DNA, 
such as enhancers and promoters, that 
reinforce lineage-specific patterns of  
gene expression.
Given the profound role of the epigenetic 
state in constraining the gene-expression 
programs available to a cell, an important 
question arises as to the role an individual 
transcription factor can have in the 
context of different epigenetic states. Can 
a transcription factor have the same role 
across lineages, or does its activity morph 
in each lineage? Can its potential roles be 
predicted on the basis of the chromatin 
landscape and the transcription-factor 
